ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

This study has been completed.
Study NCT00034255.   Last updated on June 23, 2005.   Information provided by GMP Endotherapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
2 Additional conditions recognized in this trial
Diabetes Mellitus
3 More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
4 Interventions listed in this trial
INGAP Peptide
5 Sponsors listed in this trial
GMP Endotherapeutics




Links to all studies - primarily for crawlers